stockrowLineage Cell Therapeutics, Inc. (LCTX) vs Rocket Pharmaceuticals, Inc. (RCKT)
- Lineage Cell Therapeutics, Inc. LCTX 1.02 +4.08%
- Rocket Pharmaceuticals, Inc. RCKT 2.39 −2.05%
Lineage Cell Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Lineage Cell Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($261.8M and $258.0M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −246.6%) and the higher return on invested capital (−114.7% vs −186.8%). Across the 14 metrics below, Rocket Pharmaceuticals, Inc. leads on 11 and Lineage Cell Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | LCTX | RCKT | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.46% | 0.00% | 68.51% |
| Operating margin | (205.23%) | 0.00% | 0.00% |
| Net margin | (246.58%) | 0.00% | 0.00% |
| Free cash flow margin | (186.43%) | 0.00% | 0.00% |
| Return on equity | (60.35%) | (4.77%) | (51.96%) |
| Return on assets | (32.75%) | (4.09%) | (46.06%) |
| Return on invested capital | (186.79%) | (114.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack